| 题名 | Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses. |
| 作者 | Mok TSK1, Kim SW1, Wu YL1, Nakagawa K1, Yang JJ1, Ahn MJ1, Wang J1, Yang JC1, Lu Y1, Atagi S1, Ponce S1, Shi X1, Rukazenkov Y1, Haddad V1, Thress KS1, Soria JC1. |
| 杂志 | J Clin Oncol. 2017 Dec 20;35(36):4027-4034. |
| 链接 | https://www.ncbi.nlm.nih.gov/pubmed/?term=Gefitinib+Plus+Chemotherapy+Versus+Chemotherapy+in+Epidermal+Growth+Factor+Receptor+Mutation-Positive+Non-Small-Cell+Lung+Cancer+Resistant+to+First-Line+Gefitinib+(IMPRESS)%3A+Overall+Survival+and+Biomarker+Analyses. |
| 欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |